发明名称 |
Recombinant melusin fusion protein as pharmacological agent in the treatment of heart pathologies and compositions thereof |
摘要 |
<p>A recombinant melusin fusion protein having an improved stability and a capability to reach intracellular compartments as compared to recombinant melusin in vivo , wherein said protein comprises i) a human melusin protein having the amino acid sequence as defined in SEQ ID No.:1, or a homologue thereof having at least 60%, preferably at least 80%, more preferably at least 90% sequence identity to SEQ ID No.:1 and having the function of native melusin protein or a human melusin portion derived from SEQ ID No.:1 or homologue thereof having at least 60%, preferably at least 80%, more preferably at least 90% sequence identity of the melusin portion derived from SEQ ID No.:1 and having the function of native melusin protein and ii) a cell penetrating polypeptide.</p> |
申请公布号 |
EP2386570(B1) |
申请公布日期 |
2014.02.26 |
申请号 |
EP20110165329 |
申请日期 |
2011.05.09 |
申请人 |
TARGET HEART BIOTEC S.R.L. |
发明人 |
ACCORNERO, FEDERICA;BRANCACCIO, MARA;TARONE, GUIDO;LEMBO, GIUSEPPE;CARNEVALE, DANIELA |
分类号 |
C07K14/46;A61K38/17;C12N15/12 |
主分类号 |
C07K14/46 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|